17-80287858-C-G
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PP2BP4_StrongBP6_Very_Strong
The NM_001256071.3(RNF213):āc.305C>Gā(p.Ser102Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000169 in 1,605,432 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. S102S) has been classified as Likely benign.
Frequency
Consequence
NM_001256071.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RNF213 | NM_001256071.3 | c.305C>G | p.Ser102Cys | missense_variant | 4/68 | ENST00000582970.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RNF213 | ENST00000582970.6 | c.305C>G | p.Ser102Cys | missense_variant | 4/68 | 1 | NM_001256071.3 | P2 | |
RNF213 | ENST00000319921.4 | c.305C>G | p.Ser102Cys | missense_variant | 4/17 | 1 | |||
RNF213 | ENST00000508628.6 | c.452C>G | p.Ser151Cys | missense_variant | 5/69 | 5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000920 AC: 140AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000270 AC: 63AN: 233268Hom.: 0 AF XY: 0.000174 AC XY: 22AN XY: 126560
GnomAD4 exome AF: 0.0000902 AC: 131AN: 1453132Hom.: 1 Cov.: 32 AF XY: 0.0000664 AC XY: 48AN XY: 722642
GnomAD4 genome AF: 0.000926 AC: 141AN: 152300Hom.: 0 Cov.: 33 AF XY: 0.000792 AC XY: 59AN XY: 74470
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 15, 2018 | - - |
Moyamoya disease 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 07, 2021 | - - |
RNF213-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at